Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5192265> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- Q5192265 subject Q16780215.
- Q5192265 subject Q22695562.
- Q5192265 subject Q7164690.
- Q5192265 subject Q7482753.
- Q5192265 subject Q8301163.
- Q5192265 abstract "Cubist Pharmaceuticals is a U.S. biopharmaceutical company with activities spanning from research and development to commercialization of pharmaceutical products. Its main products target pathogens like MRSA.Cubist is one of the few firms that have continued to research in antibiotics while larger pharmaceutical companies have abandoned such research. The company employs 638 people, with 370 in their headquarters in Lexington, MA. As of 2011, the company’s headquarters are under expansion and is expected to occupy 373,000 sq ft (34,700 m2) in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash (US$8.4BN) as entree to the market for drugs that can combat superbugs.".
- Q5192265 foundingYear "1992".
- Q5192265 industry Q12140.
- Q5192265 location Q929667.
- Q5192265 product products.
- Q5192265 revenue "9.264E8".
- Q5192265 thumbnail Cubist_Pharmaceuticals_Logo.svg?width=300.
- Q5192265 type Q658255.
- Q5192265 wikiPageExternalLink www.cubist.com.
- Q5192265 wikiPageExternalLink products.
- Q5192265 wikiPageExternalLink nothing-bugs-cubist-ceo-michael-bonney-2012-01-17.
- Q5192265 wikiPageWikiLink Q12140.
- Q5192265 wikiPageWikiLink Q16780215.
- Q5192265 wikiPageWikiLink Q178436.
- Q5192265 wikiPageWikiLink Q204711.
- Q5192265 wikiPageWikiLink Q22695562.
- Q5192265 wikiPageWikiLink Q247489.
- Q5192265 wikiPageWikiLink Q2903964.
- Q5192265 wikiPageWikiLink Q380775.
- Q5192265 wikiPageWikiLink Q418747.
- Q5192265 wikiPageWikiLink Q4917.
- Q5192265 wikiPageWikiLink Q595158.
- Q5192265 wikiPageWikiLink Q658255.
- Q5192265 wikiPageWikiLink Q6607583.
- Q5192265 wikiPageWikiLink Q679692.
- Q5192265 wikiPageWikiLink Q7164690.
- Q5192265 wikiPageWikiLink Q7482753.
- Q5192265 wikiPageWikiLink Q7825683.
- Q5192265 wikiPageWikiLink Q7844609.
- Q5192265 wikiPageWikiLink Q8301163.
- Q5192265 wikiPageWikiLink Q898750.
- Q5192265 wikiPageWikiLink Q929667.
- Q5192265 foundation "1992".
- Q5192265 homepage www.cubist.com.
- Q5192265 industry Q12140.
- Q5192265 keyPeople "Michael W. Bonney, President, CEO;".
- Q5192265 location Q929667.
- Q5192265 name "Cubist Pharmaceuticals, INC".
- Q5192265 products products.
- Q5192265 revenue "$926.4 million USD".
- Q5192265 type "Subsidiary of Merck".
- Q5192265 point "42.42366666666667 -71.24247222222222".
- Q5192265 type Organization.
- Q5192265 type Agent.
- Q5192265 type Company.
- Q5192265 type Organisation.
- Q5192265 type Agent.
- Q5192265 type SocialPerson.
- Q5192265 type Thing.
- Q5192265 type SpatialThing.
- Q5192265 type Q43229.
- Q5192265 comment "Cubist Pharmaceuticals is a U.S. biopharmaceutical company with activities spanning from research and development to commercialization of pharmaceutical products. Its main products target pathogens like MRSA.Cubist is one of the few firms that have continued to research in antibiotics while larger pharmaceutical companies have abandoned such research. The company employs 638 people, with 370 in their headquarters in Lexington, MA.".
- Q5192265 label "Cubist Pharmaceuticals".
- Q5192265 lat "42.42366666666667".
- Q5192265 long "-71.24247222222222".
- Q5192265 depiction Cubist_Pharmaceuticals_Logo.svg.
- Q5192265 homepage www.cubist.com.
- Q5192265 name "Cubist Pharmaceuticals, INC".